Navigation Links
Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
Date:5/8/2008

ATLANTA, May 8 /PRNewswire/ -- Alimera Sciences Inc., a privately held ophthalmic pharmaceutical company announced today that enrollment has begun for a pilot study to assess the safety and efficacy of Medidur FA in conjunction with Lucentis(R) (ranibizumab injection, Genentech) in patients with exudative age-related macular degeneration (wet AMD).

This pilot study, which will be performed under an investigator sponsored IND, will compare two doses of Medidur FA (0.2 and 0.5 ug/day) in patients who have been treated with Lucentis for at least six months. The change from baseline in parameters such as visual acuity and retinal thickness will be assessed, in addition to comparing the number of Lucentis injections post- randomization versus pre-randomization. It has been previously shown that Lucentis requires persistent dosing to maintain efficacy.

"Alimera Sciences is pleased to support this study design because it will provide preliminary information on the potential of Medidur FA to maintain the efficacy established with Lucentis while reducing the number of Lucentis treatments," said Dr. Ken Green, Senior VP and Chief Scientific Officer for Alimera Sciences.

Lucentis is an antibody that binds to VEGF, thus preventing it from interacting with its receptor and causing additional damage in patients with wet AMD. Corticosteroids inhibit VEGF secretion in addition to their anti- inflammatory action and ability to suppress leukostasis. Given these complementary actions, the concomitant use of Lucentis and Medidur is warranted in patients being treated with Lucentis for wet AMD.

AMD is a degenerative disease of the central portion of the retina (the macula) which typically occurs in patients over the age of 50. One form of the disease, exudative (or wet) AMD is characterized by the formation of leaky new blood vessels originating in the choroid which may hemorrhage and cause accumulation of sub- and intra-retinal fluid. This form of AMD
'/>"/>

SOURCE Alimera Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Pilot study reinforces use of portable anteroom HEPA filtration
2. Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO
3. Lake Hospital System Selected as Pilot Site for Health Information Literacy Research Project
4. NovoCure presents results from breast cancer pilot study
5. Researchers pilot new electronic system for infectious illness
6. VA to Pilot Innovative Remote Benefits Delivery Program
7. Phyhealth Concludes $1.5 Million Financing for Launch of Its Pilot Community-Based HMO
8. GHI and HIP Launch Pilot Medical Home Network Project with Support from Commonwealth Fund
9. Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies
10. Pilot error declines as factor in airline mishaps
11. GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)... The Accreditation Council for Continuing Medical ...on of the College of American Pathologists (CAP) t...provider of continuing medical education for physi...PRWEB) August 28, 2008 -- The Accreditation Counci...rded the Education Division of the www.cap.org [...
(Date:8/28/2008)... Leading personal injury law firm files notice of ...olice Department. , Mineo...esandersfirm.com/attorney.asp?attorneyid=14 [Marc...sonal injury law firm of Sanders, Sanders, Block, ...York, today announced that his firm has filed a No...
(Date:8/27/2008)...g. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc.,(N...f its operations reducing,its current employee hea...ons that are scheduled to take place during Septem...tions Replidyne will suspend further,development a...r the,treatment of Clostridium difficile (C. diffi...
(Date:8/27/2008)...revention experts have long known that teens are l... while driving. Now, researchers from the Meharry-...e discovered lack of seat belt use by teen passeng...t ever direct comparison of the differences betwee...lly representative teen population, the Meharry re...
Breaking Medicine News(10 mins):Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Replidyne Announces Restructuring of Operations 2Health News:Teens making poor choices when it comes to riding in vehicles 2
...rogative of choice. They seem to be partial to mid...gy Neurosurgery and Psychiatry suggests that // Fa...ptions to middle aged women with headache as compa...normally spur the patients to a doctor and account...
...Newcastle's Royal Victoria Infirmary was accused o...d from Denton Burn, Newcastle. // She was struck o...gainst her were all proved. A hearing at the Nursi...he said that she was too ill to attend the hearing...
...ve formulated a combination of drugs that could wa...long time that new borns did not feel any pain. //...nt research. The problem was how to stop this pain...n of infants. Principal investigator Anna Taddio...
...me the rage of dance lovers in discos has been fou.../ Ecstasy was first synthesised in 1910. It was p...k Pharmaceuticals as an appetite suppressant. The...loud music exacerbates the effects of ecstasy on t...
Other Medicine News:Health News:The effects of Ecstasy more pronounced in presence of music 2
(Date:8/26/2008)...ambridge Research &,Instrumentation, Inc. (CRi) an...Imaging System. The new system incorporates CRi,s ...ntry-level instrument of choice for in,vivo fluore...cgi-bin/prnh/20080826/NETU054 ), FLEX technology...que,solid-state tunable optics that for the first ...
(Date:8/26/2008)...Corporation today announced the,publication of the...g,OMS103HP in arthroscopic anterior cruciate ligam...nvestigational drug product that is added to,arthr...rove postoperative,knee function and motion, reduc... return to work. The article titled "Novel Drug Pr...
(Date:8/25/2008)...ire/ -- Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assi...for,the benefit of creditors, announced today that...sold at a sealed bid auction on October 10,2008.,...vodopa-Carbidopa that,is the current gold standard...les estimated at approximately $250 million. Signi...
(Date:8/25/2008)...d Japanese Development Studies ...25 /- Genmab has,announced ...ic lymphocytic,leukemia and non-Hodgkin,s lymphoma... begin four studies of,ofatumumab in chronic lymph... lymphoma (NHL) this year., "Genmab and GSK have ...
Breaking Medicine Technology:CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 10731 1FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 10731 2Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 1Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 2Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 3Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 4Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 5Webcast Alert 3A Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 10728 1Webcast Alert 3A Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 10728 2MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 10723 1MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 10723 2
...Pancreatic Enzyme Replacement Therapy Significantl...inical Trials, MILAN, Italy and DAYTON, Ohio, Apri...lty pharmaceutical company, today unveiled,data fr...ct,candidate, Zentase(TM), formerly EUR-1008, for ... (EPI). The US Food and Drug,Administration (FDA) ...
... Presented at the XXI Congress of the Internationa... FRANCISCO, Calif., April 04, 2007 /PRNewswire/ --...t it has received,positive results from EXPERT, a ...T054021, for the prevention of venous,thromboembol...urgery. Based on these results, Portola will advan...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 2Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: